new molecules and indications for glp-1 medicines receptor agonists next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits New Molecules and Emerging Indications

Common side effects reported with semaglutide may include nausea, vomiting, diarrhea, and constipation

Jones, Michael Ristow, Mark I

Pricing for the treatment will depend on dosing and market pricing

Addressing weight gain from antipsychotics Professor Dan Siskind, a psychiatrist and lead researcher, explained that the 36-week trial demonstrated the efficacy of semaglutide in people with schizophrenia, a population often affected by weight gain as a side effect of antipsychotic medications

[DOI] [PMC free article] [PubMed] [Google Scholar] [24].Damstra-Oddy JL, Warren EC, Perry CJ, Desfougres Y, Fitzpatrick JMK, Schaf J, et al